Dyslipidemias
Dyslipidemias(血脂异常)
Dyslipidemias 相关产品(102)
- GC44497Oleic Acid-2,6-diisopropylanilideCAS: 140112-65-8纯度: >98.00%
A hypocholesterolemic ACAT inhibitor
- GC45210α-Linolenic Acid (sodium salt)CAS: 822-18-4纯度: >95.00%
An essential ω-3 polyunsaturated fatty acid
- GC45829Troglitazone-d4纯度: >99.00%
Troglitazone-d4 是氘标记的曲格列酮。 Troglitazone 是一种 PPARγ 激动剂，对人和鼠 PPARγ 受体的 EC50 分别为 550 nM 和 780 nM。
- GC46104Butyric Acid-d7CAS: 73607-83-7纯度: >98.00%
An internal standard for the quantification of sodium butyrate
- GC467579(Z),11(E)-Conjugated Linoleic Acid (sodium salt)CAS: 756499-04-4纯度: >98.00%
An isomer of linoleic acid
- GC46892ATRA-BA HybridCAS: 1037543-26-2纯度: >95.00%
A prodrug form of all-trans retinoic acid and butyric acid
- GC47085Cholesterol-d7CAS: 83199-47-7纯度: >99.00%
An internal standard for the quantification of cholesterol
- GC47204D-Fructose-13C6CAS: 201595-65-5纯度: >99.00%
An internal standard for the quantification of D-fructose
- GC47254Docosanoic Acid-d4CAS: 1208430-53-8纯度: >99.00%
An internal standard for the quantification of docosanoic acid
- GC47281Eicosapentaenoic Acid ethyl ester-d5纯度: >99.00%
A neuropeptide with diverse biological activities
- GC47337Fenofibrate-d6CAS: 1092484-56-4纯度: >99.00%
An internal standard for the quantification of fenofibrate
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC44497 | Oleic Acid-2,6-diisopropylanilide | 140112-65-8 | >98.00% | |
A hypocholesterolemic ACAT inhibitor | ||||
| GC44529 | P053 | 2748196-63-4 | >97.00% | |
An inhibitor of ceramide synthase 1 | ||||
| GC44645 | Pioglitazone (potassium salt) | 1266523-09-4 | >98.00% | |
A PPARγ agonist | ||||
| GC44660 | Platensimycin | 835876-32-9 | >95.00% | |
A selective inhibitor of fatty acid biosynthesis | ||||
| GC44811 | Remogliflozin etabonate | 442201-24-3 | >99.00% | |
A prodrug form of remogliflozin A | ||||
| GC45060 | TMP-153 | 128831-46-9 | >95.00% | |
A potent ACAT inhibitor | ||||
| GC45210 | α-Linolenic Acid (sodium salt) | 822-18-4 | >95.00% | |
An essential ω-3 polyunsaturated fatty acid | ||||
| GC45277 | (±)-Camphene | 79-92-5 | 97.00% | |
| ||||
| GC45285 | 1,2,3-Trihexanoyl-rac-glycerol | 621-70-5 | >95.00% | |
A triacylglycerol | ||||
| GC45506 | MD001 | 2254605-76-8 | >90.00% | |
A dual agonist of PPARα and PPARγ | ||||
| GC45567 | SR 1903 | 1414248-06-8 | >98.00% | |
A modulator of RORγ and LXR receptors | ||||
| GC45829 | Troglitazone-d4 | - | >99.00% | |
Troglitazone-d4 是氘标记的曲格列酮。 Troglitazone 是一种 PPARγ 激动剂，对人和鼠 PPARγ 受体的 EC50 分别为 550 nM 和 780 nM。 | ||||
| GC46028 | Malabaricone C | 63335-25-1 | >98.00% | |
A diarylnonanoid with diverse biological activities | ||||
| GC46040 | 1,2,3-Trielaidoyl-rac-glycerol | 537-39-3 | >95.00% | |
A triacylglycerol | ||||
| GC46104 | Butyric Acid-d7 | 73607-83-7 | >98.00% | |
An internal standard for the quantification of sodium butyrate | ||||
| GC46168 | MBX-8025 (sodium salt) | - | >95.00% | |
A PPARδ agonist | ||||
| GC46471 | 17β-hydroxy Exemestane-d3 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46757 | 9(Z),11(E)-Conjugated Linoleic Acid (sodium salt) | 756499-04-4 | >98.00% | |
An isomer of linoleic acid | ||||
| GC46892 | ATRA-BA Hybrid | 1037543-26-2 | >95.00% | |
A prodrug form of all-trans retinoic acid and butyric acid | ||||
| GC47085 | Cholesterol-d7 | 83199-47-7 | >99.00% | |
An internal standard for the quantification of cholesterol | ||||
| GC47204 | D-Fructose-13C6 | 201595-65-5 | >99.00% | |
An internal standard for the quantification of D-fructose | ||||
| GC47254 | Docosanoic Acid-d4 | 1208430-53-8 | >99.00% | |
An internal standard for the quantification of docosanoic acid | ||||
| GC47281 | Eicosapentaenoic Acid ethyl ester-d5 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47337 | Fenofibrate-d6 | 1092484-56-4 | >99.00% | |
An internal standard for the quantification of fenofibrate | ||||